Back to Search Start Over

PRECISION 1: A phase 2, multicenter, open-label basket trial of nab -sirolimus for malignant solid tumors harboring pathogenic inactivating alterations in TSC1 and TSC2.

Authors :
Deming, Dustin A.
Kwiatkowski, David J.
Ding, Li
Schmid, Anita N.
Navarro, Willis H.
Rodon Ahnert, Jordi
Iyer, Gopa
Source :
Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, pTPS585-TPS585, 151p
Publication Year :
2024

Details

Language :
English
ISSN :
0732183X
Volume :
42
Database :
Supplemental Index
Journal :
Journal of Clinical Oncology
Publication Type :
Academic Journal
Accession number :
174954936
Full Text :
https://doi.org/10.1200/JCO.2024.42.3_suppl.TPS585